130 related articles for article (PubMed ID: 32603867)
1. A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity.
Sánchez-García L; Sala R; Serna N; Álamo P; Parladé E; Alba-Castellón L; Voltà-Durán E; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A
Acta Biomater; 2020 Sep; 113():584-596. PubMed ID: 32603867
[TBL] [Abstract][Full Text] [Related]
2. Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4
Sala R; Sánchez-García L; Serna N; Céspedes MV; Casanova I; Roldán M; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A
Acta Biomater; 2019 Nov; 99():426-432. PubMed ID: 31494293
[TBL] [Abstract][Full Text] [Related]
3. Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines.
Álamo P; Cedano J; Conchillo-Sole O; Cano-Garrido O; Alba-Castellon L; Serna N; Aviñó A; Carrasco-Diaz LM; Sánchez-Chardi A; Martinez-Torró C; Gallardo A; Cano M; Eritja R; Villaverde A; Mangues R; Vazquez E; Unzueta U
Acta Biomater; 2021 Aug; 130():211-222. PubMed ID: 34116228
[TBL] [Abstract][Full Text] [Related]
4. Design of integrin α
Lv X; Zhang C; Shuaizhen Q; Yu R; Zheng Y
Biomed Pharmacother; 2020 Aug; 128():110236. PubMed ID: 32447209
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles.
Martínez-Torró C; Alba-Castellón L; Carrasco-Díaz LM; Serna N; Imedio L; Gallardo A; Casanova I; Unzueta U; Vázquez E; Mangues R; Villaverde A
Biomed Pharmacother; 2023 Aug; 164():114976. PubMed ID: 37276641
[TBL] [Abstract][Full Text] [Related]
6. Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs.
Sánchez-García L; Serna N; Álamo P; Sala R; Céspedes MV; Roldan M; Sánchez-Chardi A; Unzueta U; Casanova I; Mangues R; Vázquez E; Villaverde A
J Control Release; 2018 Mar; 274():81-92. PubMed ID: 29408658
[TBL] [Abstract][Full Text] [Related]
7. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
8. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
Zhang J; Huang K; O'Neill KL; Pang X; Luo X
Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
[TBL] [Abstract][Full Text] [Related]
9. Pro-apoptotic peptides-based cancer therapies: challenges and strategies to enhance therapeutic efficacy.
Min KA; Maharjan P; Ham S; Shin MC
Arch Pharm Res; 2018 Jun; 41(6):594-616. PubMed ID: 29804279
[TBL] [Abstract][Full Text] [Related]
10. High-precision targeting and destruction of cancer-associated PDGFR-β
Voltà-Durán E; Alba-Castellón L; Serna N; Casanova I; López-Laguna H; Gallardo A; Sánchez-Chardi A; Villaverde A; Unzueta U; Vázquez E; Mangues R
Acta Biomater; 2023 Oct; 170():543-555. PubMed ID: 37683965
[TBL] [Abstract][Full Text] [Related]
11. Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticles.
Voltà-Durán E; Serna N; Sánchez-García L; Aviñó A; Sánchez JM; López-Laguna H; Cano-Garrido O; Casanova I; Mangues R; Eritja R; Vázquez E; Villaverde A; Unzueta U
Acta Biomater; 2021 Jan; 119():312-322. PubMed ID: 33189955
[TBL] [Abstract][Full Text] [Related]
12. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
13. Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4
Cano-Garrido O; Álamo P; Sánchez-García L; Falgàs A; Sánchez-Chardi A; Serna N; Parladé E; Unzueta U; Roldán M; Voltà-Durán E; Casanova I; Villaverde A; Mangues R; Vázquez E
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208189
[TBL] [Abstract][Full Text] [Related]
14. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.
Rueda F; Céspedes MV; Sánchez-Chardi A; Seras-Franzoso J; Pesarrodona M; Ferrer-Miralles N; Vázquez E; Rinas U; Unzueta U; Mamat U; Mangues R; García-Fruitós E; Villaverde A
Microb Cell Fact; 2016 Apr; 15():59. PubMed ID: 27059706
[TBL] [Abstract][Full Text] [Related]
16. Protein-Based Therapeutic Killing for Cancer Therapies.
Serna N; Sánchez-García L; Unzueta U; Díaz R; Vázquez E; Mangues R; Villaverde A
Trends Biotechnol; 2018 Mar; 36(3):318-335. PubMed ID: 29246477
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles.
Álamo P; Pallarès V; Céspedes MV; Falgàs A; Sanchez JM; Serna N; Sánchez-García L; Voltà-Duràn E; Morris GA; Sánchez-Chardi A; Casanova I; Mangues R; Vazquez E; Villaverde A; Unzueta U
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33105866
[TBL] [Abstract][Full Text] [Related]
18. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
20. Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy.
Shim MK; Moon Y; Yang S; Kim J; Cho H; Lim S; Yoon HY; Seong JK; Kim K
Biomaterials; 2020 Dec; 261():120347. PubMed ID: 32889501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
